Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Revenue Rocket Advises Uptime Legal Systems in Strategic Acquisition of LexCloud
-
Lifetime Brands Announces Third Quarter 2024 Financial Results Release Date and Conference Call
-
FLYR Announces Major Upgrade of FLYR Hospitality Insights, Accelerating Business Intelligence for the Hotel Industry
-
World’s First End-to-End AI Voice Hotel Reservationist takes 10,000 calls a day
-
Marex Group plc Announces Pricing of U.S.$600 Million Senior Notes Offering
-
e-therapeutics Announces Business Updates and Interim Results
-
Spryker Announces Product Updates To Enable Efficient Scaling For Global Enterprises
-
HMNC Brain Health to Present Advances in Precision Psychiatry and Psychedelics at CNS Summit 2024 in Boston
-
Object Management Group Announces Cross-Consortia Artificial Intelligence Joint Working Group
-
Hunter Versus Spy: Sophos “Pacific Rim” Report Details its Defensive and Counter-Offensive Operation with Multiple Interlinked Adversaries Based in China
-
First Advantage Completes Acquisition of Sterling Check for $2.2 Billion
-
Ninepoint Partners Announces Final October 2024 Cash Distribution for Ninepoint Cash Management Fund - ETF Series
-
Parfin Hires Jiten Varu, Ex-AWS, to Lead International Expansion
-
Illinois Lottery Reports Record Results for Third Consecutive Year
-
Hrvatski Telekom and Nokia announce API pilot projects to expand 5G application development in Croatia
-
AITX to Transition to OTCID Market Classification
-
Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant
-
Banzai Launches Curate: A Groundbreaking AI-Driven Newsletter Solution
-
Mega 97.9 Now Available on TuneIn Premium for Commercial-Free Listening Experience
-
Global Water Resources Declares Monthly Dividend
-
Hudson Global to Report Third Quarter 2024 Financial Results on November 12th
-
Rigetti and Riverlane Progress Towards Fault Tolerant Quantum Computing with Real-Time and Low Latency Error Correction on Rigetti QPU
-
CEMATRIX To Report Third Quarter Results On November 7, 2024
-
InterDigital Announces Financial Results for Third Quarter 2024
-
Navitas Showcases World’s First 8.5kW AI Data Center Power Supply Using GaN & SiC at China’s Premier Power Electronics Conference
-
Alkeus Pharmaceuticals Appoints David Arkowitz as Chief Financial Officer
-
Hallador Energy Company Schedules Third Quarter 2024 Conference Call for November 12, 2024 at 5:00 p.m. ET
-
Aeries Technology is Great Place To Work® Certified
-
Navitas Showcases World’s First 8.5kW AI Data Center Power Supply Using GaN & SiC at China’s Premier Power Electronics Conference
-
SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE
-
Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2024
-
METALSOURCE MINING ANNOUNCES $1,500,000 PRIVATE PLACEMENT, WITH LEAD ORDER FROM ERIC SPROTT
-
Gulf Resources Releases Letter to Shareholders
-
HYCU® Recognized as CRN 2024 Product of the Year Finalist
-
PLBY Group Announces Strategic Partnership with Byborg Enterprises SA
-
Heritage Distilling Names Army Veteran, Sara Kellerman, as Vice President, Salute Series
-
GigaCloud Technology Inc to Announce Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024
-
Elicio Therapeutics to Present Clinical Data at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting and Stand Up to Cancer (SU2C) Innovation Summit
-
Palisade Bio Announces Positive Data from Two Ex Vivo Translational Studies of PALI-2108 for the Treatment of Ulcerative Colitis
-
IMUNON to Hold Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 7, 2024
-
Intelligent Bio Solutions Partners with B2i Digital to Amplify Investor Outreach
-
Itron Announces Third Quarter 2024 Financial Results
-
Cassava Sciences to Report Third Quarter 2024 Results on November 7, 2024
-
Samba TV Announces Acquisition of Semasio, Strengthening its Position in Contextual Targeting
-
Tizona Therapeutics Announces Expansion of Phase 1b Clinical Trial to Evaluate TTX-080 in Combination with EGFR Inhibitor Cetuximab and Chemotherapy in Advanced Colorectal Cancer
-
Lisata Therapeutics to Participate in Upcoming November 2024 Industry and Investor Events
-
CalypsoAI Recognized as One of the Most Important VC-backed Cybersecurity Companies of 2024 on Fortune’s Cyber 60 List
-
Brightspeed Donates $25,000 for Storm Relief, Continues On-the-Ground Support
-
Duda Agency Expands Partnership with Bridgeline’s WooRank
-
Opening of new mortgage covered bonds (SDRO) financing FlexLån®


